ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Synthetic enzyme syndrome associated with symmetrical multiple sclerosis

Symmetrical polyarthritis is a dubious disease in the field of autoimmune and rheumatic immunity, clinical manifestations are complex and often involve multiple systems. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of this disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological activation.

The platform can help to combine teams of authoritative experts at home and abroad to provide accurate diagnostics and treatment programs. Treatment and management of symmetrical polyarthritis requires individualized development, typically including drug therapy, rehabilitation interventions, regular follow-up, and multidimensional management. In recent years, with the development of therapeutically oriented, immune-regulatory therapies and precision medicine, many previously difficult-to-treat autoimmune and rheumatoid immune disorders have been significantly improved.

Therapeutic efficacy and adverse reactions need to be closely monitored and timely adjusted according to disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of symmetric multiple arthritis associated with synthetase syndrome. The platform serves the China International Medical Service System, which combines national and international authorities in the field of autoimmunity and rheumatic immunity to provide the following services to patients: 1.

Remote pre-diagnosis: pre-examination of medical records, clear diagnostic directions and medical advice by the team of experts; 2. Interviews in China: arranging face-to-face diagnostics with authorities, developing personalized treatment plans; 3. Full-service: one-stop services: providing medical translation, medical care, accommodation arrangements; 4.

Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.